ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 22 filers reported holding ARIDIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29,950 | -81.8% | 136,197 | -74.1% | 0.00% | – |
| Q1 2023 | $164,951 | -73.3% | 525,156 | +0.1% | 0.00% | – |
| Q4 2022 | $618,854 | +26.8% | 524,453 | +0.1% | 0.00% | – |
| Q3 2022 | $488,000 | -15.4% | 524,122 | 0.0% | 0.00% | – |
| Q2 2022 | $577,000 | -37.4% | 524,122 | 0.0% | 0.00% | – |
| Q1 2022 | $922,000 | -22.0% | 524,122 | +3.3% | 0.00% | – |
| Q4 2021 | $1,182,000 | +89.4% | 507,337 | +199.2% | 0.00% | – |
| Q3 2021 | $624,000 | -47.3% | 169,537 | +6.0% | 0.00% | – |
| Q2 2021 | $1,184,000 | +34.1% | 159,946 | +6.9% | 0.00% | – |
| Q1 2021 | $883,000 | -1.2% | 149,658 | +1.5% | 0.00% | – |
| Q4 2020 | $894,000 | -14.4% | 147,424 | 0.0% | 0.00% | – |
| Q3 2020 | $1,044,000 | +111.8% | 147,424 | +98.4% | 0.00% | – |
| Q2 2020 | $493,000 | +14.9% | 74,302 | 0.0% | 0.00% | – |
| Q1 2020 | $429,000 | +29.6% | 74,302 | 0.0% | 0.00% | – |
| Q4 2019 | $331,000 | -39.9% | 74,302 | -9.4% | 0.00% | – |
| Q3 2019 | $551,000 | +25.2% | 81,966 | +89.4% | 0.00% | – |
| Q2 2019 | $440,000 | -12.4% | 43,281 | -5.2% | 0.00% | – |
| Q1 2019 | $502,000 | – | 45,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wealth Architects, LLC | 14,077 | $1,437 | 0.00% |